⌘K
Loading ticker…
Journey Medical Corporation Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, Journey Medical Corporation Common Stock (DERM) has a 3-month relative strength percentile of 85 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 52. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 6.3%, relative volume 8.19×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
3m RS is 85, Market Stance is mixed at 47, A/D rating A
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY diluted average shares. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Strong relative strength with attention running hot versus its own recent norm. The trend is intact but well-noticed; elevated retail attention has historically been associated with softer forward returns. Context, not a call.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
Related searches
DERM is held by 4 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $4M notional. Top 3 carry $7M.
Top 4 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $4M |
| IWMiShares Russell 2000 ETF | 0.00% | $2M |
| VXFVanguard Extended Market ETF | 0.00% | $1M |
| IWOiShares Russell 2000 Growth ETF | 0.01% | $755K |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | DERM Jan avg: 7.07% median: 12.40% win: 75% σ: 15.92% n: 4 2022-04-12 → 2026-05-29 | DERM Feb avg: -6.04% median: -10.42% win: 25% σ: 22.36% n: 4 2022-04-12 → 2026-05-29 | DERM Mar avg: -12.66% median: -6.41% win: 25% σ: 20.65% n: 4 2022-04-12 → 2026-05-29 | DERM Apr avg: 4.76% median: 9.81% win: 80% σ: 17.64% n: 5 2022-04-12 → 2026-05-29 | DERM May avg: 1.29% median: 5.69% win: 80% σ: 19.76% n: 5 2022-04-12 → 2026-05-29 | DERM Jun avg: 15.85% median: 14.85% win: 50% σ: 27.13% n: 4 2022-04-12 → 2026-05-29 (current) | DERM Jul avg: 5.47% median: 1.05% win: 50% σ: 10.73% n: 4 2022-04-12 → 2026-05-29 | DERM Aug avg: -2.62% median: -5.55% win: 25% σ: 9.74% n: 4 2022-04-12 → 2026-05-29 | DERM Sep avg: 3.22% median: 6.10% win: 50% σ: 23.64% n: 4 2022-04-12 → 2026-05-29 | DERM Oct avg: 7.75% median: 7.91% win: 75% σ: 14.09% n: 4 2022-04-12 → 2026-05-29 | DERM Nov avg: 1.47% median: -0.05% win: 50% σ: 18.85% n: 4 2022-04-12 → 2026-05-29 | DERM Dec avg: 1.19% median: 1.10% win: 50% σ: 27.83% n: 4 2022-04-12 → 2026-05-29 |